CareTaker Medical
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$3.4m | Series A | ||
N/A | - | ||
N/A | N/A | Late VC | |
* | N/A | $7.4m | Late VC |
Total Funding | AUD16.6m |
Related Content
Recent News about CareTaker Medical
EditCaretaker Medical offers a comprehensive vital sign monitoring platform that connects clinicians to their patients, whether in hospitals, at home, or in mobile settings. The core product is a noninvasive, wearable device that continuously monitors all essential vital signs with ICU-level accuracy. The device uses an FDA-cleared finger cuff and Pulse Decomposition Analysis technology to measure blood pressure, blood oxygen levels (SpO2), and respiration rate without the need for bulky wires or arm cuffs. This enhances patient comfort and clinician productivity by providing real-time streaming data for better clinical decision-making. The primary clients are healthcare providers, including hospitals, emergency services, and home healthcare agencies. Caretaker Medical operates in the healthcare technology market, focusing on improving patient safety and clinical outcomes through advanced monitoring solutions. The business model is based on the sale and subscription of its monitoring devices and software services. Revenue is generated through the initial sale of the devices and ongoing subscription fees for the monitoring platform and data services.
Keywords: vital sign monitoring, noninvasive, wearable device, ICU-level accuracy, healthcare technology, patient safety, real-time data, Pulse Decomposition Analysis, emergency services, home healthcare.